Top ten highlights from the APAC PE, VC, and startup ecosystem this week:
- Indian Startup Fundraising Slows Down: Fundraising by Indian startups hit a new low in Q3 2025, with private equity and venture capital investments dropping to $3 billion.
- Greater China Startup Funding Surges: Startups in Greater China raised nearly $3.6 billion in September, marking a 36.5% increase in deal value compared to August.
- Earnings Highlights: Indonesia’s GoTo Group and Bukalapak reported improved financial performance, while Swiggy in India saw a narrower second-quarter loss.
- Stockbit Pte Ltd’s Profitability Boost: The Singapore holding company for Stockbit and Bibit trimmed its net loss in 2023 due to higher revenue and reduced marketing expenses.
- Investment Updates: Temasek is in talks to invest in Somerset Indus Capital Partners’ third fund, KV Asia Capital is finalising its third private equity fund, and Lighthouse Canton plans to invest over $1.5 billion in India.
- Deal News: Notable deals include Kopi Kenangan’s backers selling stake, layoffs at Blibli and Paper.id, and ObvioHealth raising capital from existing and new investors.
- Funding Rounds: Various startups secured funding, such as Moladin raising around $35 million and Optimo Capital raising Rs 150 crore in a Series A round.
- Global Investments: Ant International’s strategic investment in R2, FundPark’s $71 million raise, and Prosus and Accel’s $1 million investments in startups.
- Technology Advances: JBD’s $140.4 million funding round, VoidZero’s $12.5 million in Series A round, and 2C2P’s rebrand and $60 million investment plan.
- Industry Insights: Snapmint’s fresh funding, Deep dives into renewable energy cost-competitiveness and Sea Limited’s investor attention shift.
APAC Private Markets Research
Explore latest Insights on APAC Private Markets on Smartkarma
Disclaimer:This article by is general in nature and based on publicly available information and not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material. While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
Also, check out the latest in ECM Research on Smartkarma
